» Articles » PMID: 22155870

Control-FREEC: a Tool for Assessing Copy Number and Allelic Content Using Next-generation Sequencing Data

Overview
Journal Bioinformatics
Specialty Biology
Date 2011 Dec 14
PMID 22155870
Citations 538
Authors
Affiliations
Soon will be listed here.
Abstract

Summary: More and more cancer studies use next-generation sequencing (NGS) data to detect various types of genomic variation. However, even when researchers have such data at hand, single-nucleotide polymorphism arrays have been considered necessary to assess copy number alterations and especially loss of heterozygosity (LOH). Here, we present the tool Control-FREEC that enables automatic calculation of copy number and allelic content profiles from NGS data, and consequently predicts regions of genomic alteration such as gains, losses and LOH. Taking as input aligned reads, Control-FREEC constructs copy number and B-allele frequency profiles. The profiles are then normalized, segmented and analyzed in order to assign genotype status (copy number and allelic content) to each genomic region. When a matched normal sample is provided, Control-FREEC discriminates somatic from germline events. Control-FREEC is able to analyze overdiploid tumor samples and samples contaminated by normal cells. Low mappability regions can be excluded from the analysis using provided mappability tracks.

Availability: C++ source code is available at: http://bioinfo.curie.fr/projects/freec/

Contact: freec@curie.fr

Supplementary Information: Supplementary data are available at Bioinformatics online.

Citing Articles

Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial.

Shitara K, Janjigian Y, Ajani J, Moehler M, Yao J, Wang X Nat Med. 2025; .

PMID: 40055521 DOI: 10.1038/s41591-025-03575-0.


Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients.

Yin X, Shen H, Wang H, Wang Q, Zhang S, Zhang C Nat Commun. 2025; 16(1):2214.

PMID: 40044664 PMC: 11882848. DOI: 10.1038/s41467-025-57520-3.


Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors.

Corbett R, Kaufman R, McQuaid S, Vaksman Z, Phul S, Brown M medRxiv. 2025; .

PMID: 39974082 PMC: 11838646. DOI: 10.1101/2025.02.04.25321499.


Transgressive expression and dosage effect of A09 chromosome genes and their homoeologous genes influence the flowering time of resynthesized allopolyploid Brassica napus.

Bai Y, Zhao K, Wang B, Wu L, Xiong Z BMC Plant Biol. 2025; 25(1):226.

PMID: 39972272 PMC: 11837392. DOI: 10.1186/s12870-025-06236-z.


Insufficient gene expression and lost gene regulatory network may underlie the mechanism of Hirschsprung Disease in 5p-syndrome.

Luan Y, Li P, Luo Y, Zhang H, Zhu X, Zhang Y Heliyon. 2025; 11(3):e42079.

PMID: 39959475 PMC: 11830294. DOI: 10.1016/j.heliyon.2025.e42079.


References
1.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

2.
Sherry S, Ward M, Kholodov M, Baker J, Phan L, Smigielski E . dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2000; 29(1):308-11. PMC: 29783. DOI: 10.1093/nar/29.1.308. View

3.
Sathirapongsasuti J, Lee H, Horst B, Brunner G, Cochran A, Binder S . Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV. Bioinformatics. 2011; 27(19):2648-54. PMC: 3179661. DOI: 10.1093/bioinformatics/btr462. View

4.
Popova T, Manie E, Stoppa-Lyonnet D, Rigaill G, Barillot E, Stern M . Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays. Genome Biol. 2009; 10(11):R128. PMC: 2810663. DOI: 10.1186/gb-2009-10-11-r128. View

5.
Suzuki S, Moore 2nd D, Ginzinger D, Godfrey T, Barclay J, Powell B . An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res. 2000; 60(19):5382-5. View